메뉴 건너뛰기
Journal of Clinical Pharmacology
Volumn 53, Issue 4, 2013, Pages 456-458
Dabigatran-induced hyperkalemia in a renal transplant recipient: A clinical observation
Author keywords

Ambulatory care (AMB); Cardiovascular (CAR); Clinical pharmacology (CPH); Education (EDU); Internal medicine (INT); Nephrology (NEP)
Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE; ALLOPURINOL; AMLODIPINE; CARVEDILOL; DABIGATRAN; DILTIAZEM; DOMPERIDONE; FLUDROCORTISONE; FUROSEMIDE; INSULIN ASPART; INSULIN GLARGINE; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NORADRENALIN; PANTOPRAZOLE; POTASSIUM; RENIN; REPAGLINIDE; SIMVASTATIN; TACROLIMUS;
EID: 84877870722     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.21     Document Type: Article
Times cited : (3)
References (11)
  • 1
    • 0029000397 scopus 로고
    • Herparin-induced aldosterone suppression and hyperkalemia
    • Oster JR, Singer I, Fishman LM. Herparin-induced aldosterone suppression and hyperkalemia. Am J Med. 1995;98:575-586.
    • (1995) Am J Med , vol.98 , pp. 575-586
    • Oster, J.R.1    Singer, I.2    Fishman, L.M.3
  • 2
    • 0033825899 scopus 로고    scopus 로고
    • Drug-induced hyperkalemia: Old culprits and new offenders
    • Perazella MA. Drug-induced hyperkalemia: old culprits and new offenders. Am J Med. 2000;109:307-314.
    • (2000) Am J Med , vol.109 , pp. 307-314
    • Perazella, M.A.1
  • 3
    • 61549118522 scopus 로고    scopus 로고
    • The management of hyperkalemia in patients with cardiovascular disease
    • Khanna A, White WB. The management of hyperkalemia in patients with cardiovascular disease. Am J Med. 2009;122:215-221.
    • (2009) Am J Med , vol.122 , pp. 215-221
    • Khanna, A.1    White, W.B.2
  • 4
    • 79958126202 scopus 로고    scopus 로고
    • Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (rely) trial
    • Eikelboom JW, Wallentin L, Connolly SJ, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RELY) trial. Circulation. 2011;123:2363-2372.
    • (2011) Circulation , vol.123 , pp. 2363-2372
    • Eikelboom, J.W.1    Wallentin, L.2    Connolly, S.J.3
  • 5
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009; 361:1139-1151.
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 6
    • 0033593072 scopus 로고    scopus 로고
    • Warfarin use among ambulatory patients with non-valvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (atria) study
    • Go AS, Hylek EM, Borowsky LH, et al. Warfarin use among ambulatory patients with non-valvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med. 1999;131:927-34.
    • (1999) Ann Intern Med , vol.131 , pp. 927-34
    • Go, A.S.1    Hylek, E.M.2    Borowsky, L.H.3
  • 7
    • 41949116970 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate
    • Strangier J. Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate. Clin Pharacokinet. 2008;47(5):285-295.
    • (2008) Clin Pharacokinet , vol.47 , Issue.5 , pp. 285-295
    • Strangier, J.1
  • 8
    • 0018903207 scopus 로고
    • Adrenergic modulation of extrarenal potassium disposal
    • Rosa RM, Silva P, Young JB, et al. Adrenergic modulation of extrarenal potassium disposal. NEJM. 1980;302:431-434.
    • (1980) NEJM , vol.302 , pp. 431-434
    • Rosa, R.M.1    Silva, P.2    Young, J.B.3
  • 9
    • 0035854054 scopus 로고    scopus 로고
    • Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation
    • Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation. JAMA. 2001;285:2864.
    • (2001) JAMA , vol.285 , pp. 2864
    • Gage, B.F.1    Waterman, A.D.2    Shannon, W.3
  • 10
    • 0019799332 scopus 로고
    • A method for estimating the probability of adverse drug reactions
    • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30(2):239-245.
    • (1981) Clin Pharmacol Ther , vol.30 , Issue.2 , pp. 239-245
    • Naranjo, C.A.1    Busto, U.2    Sellers, E.M.3
  • 11
    • 0016904570 scopus 로고
    • Use of drugs in myopathies
    • Grob D. Use of drugs in myopathies. Ann Rev Pharmacol Toxicol. 1976;16:215-229.
    • (1976) Ann Rev Pharmacol Toxicol , vol.16 , pp. 215-229
    • Grob, D.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.